| 3.05 -0.19 (-5.86%) | 06-16 00:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 66.94 |
1-year : | 70.78 |
| Resists | First : | 57.31 |
Second : | 60.59 |
| Pivot price | 54.85 |
|||
| Supports | First : | 52 |
Second : | 43.26 |
| MAs | MA(5) : | 53.22 |
MA(20) : | 55.94 |
| MA(100) : | 53.65  |
MA(250) : | 52.13 |
|
| MACD | MACD : | -1.1 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 6.2 |
D(3) : | 9.8 |
| RSI | RSI(14): 30 |
|||
| 52-week | High : | 60.59 | Low : | 41.7 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.[ OLN ] has closed above bottom band by 17.8%. Bollinger Bands are 50.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 53.73 - 54.09 | 54.09 - 54.39 |
| Low: | 51.87 - 52.22 | 52.22 - 52.51 |
| Close: | 52.55 - 53.13 | 53.13 - 53.6 |
Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallow able capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. As of February 27, 2020, it had three company-managed retail treatment centers in California. Obalon Therapeutics, Inc. was founded in 2008 and is headquartered in Carlsbad, California.
Fri, 22 Sep 2023
Gastric Balloon Market include Apollo Endosurgery, Inc., - openPR
Wed, 21 Apr 2021
Top Reddit Penny Stocks To Buy Today? 3 To Watch Right Now - Penny Stocks
Fri, 08 May 2020
William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director - GlobeNewswire
Fri, 24 Apr 2020
Europe Intragastric Balloon Market to Rear Excessive Growth During 2020-2026 - openPR
Tue, 14 Apr 2020
Are These The Best Penny Stocks To Buy Right Now? - Penny Stocks
Thu, 22 Aug 2019
The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrop - Benzinga
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 120 (M) |
| Shares Float | 120 (M) |
| Held by Insiders | 0.3 (%) |
| Held by Institutions | 90.2 (%) |
| Shares Short | 2,760 (K) |
| Shares Short P.Month | 2,510 (K) |
| EPS | 3.56 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 18.56 |
| Profit Margin | 6.7 % |
| Operating Margin | 6 % |
| Return on Assets (ttm) | 6.2 % |
| Return on Equity (ttm) | 18.7 % |
| Qtrly Rev. Growth | -18.3 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 57.08 |
| EBITDA (p.s.) | 11.11 |
| Qtrly Earnings Growth | -70 % |
| Operating Cash Flow | 974 (M) |
| Levered Free Cash Flow | 702 (M) |
| PE Ratio | 14.58 |
| PEG Ratio | 0.6 |
| Price to Book value | 2.8 |
| Price to Sales | 0.91 |
| Price to Cash Flow | 6.39 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|